The import forecast for penicillins or streptomycins not in dosage forms to Italy predicts a steady growth from 2024 to 2028, with values increasing from USD 70.876 million to USD 81.959 million. This upward trend indicates a compound annual growth rate (CAGR) from 2024 to 2028. The anticipated year-on-year increases showcase consistent growth throughout the forecast period.

Future trends to watch for include:

Potential shifts in global supply chain dynamics due to geopolitical factors or trade policy changes.
Technological advancements in antibiotic production that may impact import values.
Regulatory changes within the EU affecting the pharmaceutical sector.
Fluctuations in demand driven by public health needs or new medical guidelines.